NCT06667934View on ClinicalTrials.gov

Clinical Trial of Zuoqing SAN in Treating Ulcerative Colitis

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 30, 2024

Primary Completion Date

May 1, 2025

Study Completion Date

May 1, 2025

Conditions
Ulcerative Colitis (UC)
Interventions
DRUG

Zuoqing powder was dissolved in 100ml normal saline, retained enema, once a night

Zuoqing powder was dissolved in 100ml normal saline, retained enema, once a night

DRUG

Methalazine suppository was given rectally once a day

Methalazine suppository was given rectally once a day

All Listed Sponsors
lead

The Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine

OTHER

NCT06667934 - Clinical Trial of Zuoqing SAN in Treating Ulcerative Colitis | Biotech Hunter | Biotech Hunter